Table 1. Diagnostic value of candidate biomarkers of liver fibrosis.
Value | Sens | Spec | Predictive value | AUC | Publication, yearRef | Etiology | Definition of fibrosis | |
Gas6 | 30 ng/mL | 84% | 56% | N/A | 0.734 | Bellan et al. 201646 | Mixed, 92% viral | Ishak ≤1 |
42 ng/mL | 64% | 95% | N/A | 0.788 | Bellan et al. 201646 | Ishak ≥4 | ||
M2BP | 2.21 C.O.I. | 88.2% | 78.7% | PPV 58.9%, NPV 94.5% | 0.812 | Toshima et al. 201550 | HCV | Metavir ≥3 |
1.00 C.O.I. | 67% | 70% | PPV 53%, NPV 81% | 0.680 | Nakamura et al. 201752 | HBV | Ishak ≥3 | |
2.00 C.O.I. | 69% | 74% | PPV 57%, NPV 83% | 0.795 | Nakamura et al. 201752 | HCV | Ishak ≥3 | |
1.57 C.O.I. | 85.9% | 74.6% | N/A | 0.879 | Abe et al. 201553 | NAFLD | Metavir ≥3 | |
1.40 C.O.I. | 83% | 90% | PPV 69%, NPV 95% | 0.933 | Umemura et al. 201554 | PBC | Metavir ≥3 | |
3.70 C.O.I. | 64.3% | 83.3% | N/A | 0.747 | Nishikawa et al. 201655 | Autoimmune hepatitis | Metavir ≥3 | |
OPN | 2.9 ng/mL | 96.4% | 94.1% | N/A | 0.957 | Huang et al. 201077 | HCV | Metavir ≥3 |
124 ng/mL | 97.1% | 100% | N/A | 0.997 | Matsue et al. 201579 | HCV | Metavir ≥3 | |
PlGF | 20.2 pg/mL | 79% | 63% | N/A | 0.758 | Krawczyk et al. 201784 | Mixed | Desmet Scheuer ≥2 |
21.9 pg/mL | N/A | N/A | N/A | 0.771 | Krawczyk et al. 201784 | Mixed | Desmet Scheuer ≥3 | |
GDF15 | 1582.8 pg/mL | 94% | 67% | N/A | 0.854 | Krawczyk et al. 201784 | Mixed | Desmet Scheuer ≥2 |
1563.7 pg/mL | N/A | N/A | N/A | 0.901 | Krawczyk et al. 201784 | Mixed | Desmet Scheuer ≥3 | |
HGF | 2598 pg/mL | 97% | 64% | N/A | 0.849 | Krawczyk et al. 201784 | Mixed | Desmet Scheuer ≥2 |
2085.7 pg/mL | N/A | N/A | N/A | 0.888 | Krawczyk et al. 201784 | Mixed | Desmet Scheuer ≥3 |
Abbreviations: AUC, area under the curve; C.O.I., cut-off index; M2BP, Mac-2 binding protein; GDF15, growth differentiation factor 15; HGF, hepatocyte growth factor; N/A, not available; NPV, negative predictive value; OPN, osteopontin; PlGF, placental growth factor; PPV, positive predictive value; Sens, sensitivity; Spec, specificity.